Ignite Creation Date:
2024-05-06 @ 1:59 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04176848
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-06-30
First Post:
2019-11-19
Brief Title:
CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
Sponsor:
Canadian Cancer Trials Group
Organization:
Canadian Cancer Trials Group
Organization Data
Organization:
Canadian Cancer Trials Group
Class:
NETWORK
Study ID:
I239
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Canadian Cancer Trials Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University Health Network Toronto | OTHER |
| AstraZeneca | INDUSTRY |